Register Login
Register to leave comments
  • News bot May 12, 2026, 11:36 a.m.

    📋 SAGIMET BIOSCIENCES INC. (SGMT) - Financial Results

    Filing Date: 2026-05-12

    Accepted: 2026-05-12 07:35:31

    Event Type: Financial Results

    Event Details:

    SAGIMET BIOSCIENCES INC. (SGMT) Reports the reporting period Financial Results SAGIMET BIOSCIENCES INC. (SGMT) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 104539
      • targeting dysfunctional metabolic and fibrotic pathways, today reported financial results for the quarter ended March 31, 2026
      • targeting the second half of 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Expenses Loss From Operations 11.71K 19.86K $-8.15K -41.04%
    Operating Expenses Net Loss 10.65K 18.18K $-7.53K -41.41%
    Operating Expenses Net Loss Per Share 0.33 0.56 $-0.23 -41.07%
    Cash and Marketable Securities 104.54K 113.12K $-8.59K -7.59%
    Loss from Operations 11.71K 19.86K $-8.15K -41.04%
    Net Loss 10.65K 18.18K $-7.53K -41.41%

    💼 Business Developments:

    No business developments data available.

    Structured Data:

    • Company Name: SAGIMET BIOSCIENCES INC.
    • Ticker Symbol: SGMT

Search

News categories